SCHEDULE: L1 Capital Discloses 0.33% Stake in ReShape Lifesciences
Beneficial Ownership Disclosure
L1 Capital Global Opportunities Master Fund, Ltd. has filed an amended Schedule 13G, disclosing beneficial ownership of 0.33% of ReShape Lifesciences Inc.'s common stock.
Summary
- L1 Capital Global Opportunities Master Fund, Ltd. reported beneficial ownership of 7,862 shares of ReShape Lifesciences Inc. common stock.
- This stake represents 0.33% of the company's outstanding common stock.
- The beneficially owned shares are underlying warrants.
- The percentage of class is calculated based on 2,385,960 common shares outstanding after a previous offering, as detailed in the Issuer's Prospectus Supplement filed with the SEC on June 9, 2025.
- L1 Capital Global Opportunities Master Fund, Ltd. holds sole voting and sole dispositive power over these 7,862 shares.
- David Feldman and Joel Arber are the Directors of L1 Capital Global Opportunities Master Fund, Ltd.
Sentiment
Score: 5
Explanation: This is a routine ownership disclosure filing (Schedule 13G) by an institutional investor, indicating a passive stake. It does not contain operational or financial performance data for the issuer, thus the sentiment is neutral.
Future Outlook
NA
Industry Context
NA
Key Dates
| Date | Description |
|---|---|
| 06/09/2025 | Issuer's Prospectus Supplement filed under Rule 424(b)(5) with the Securities and Exchange Commission, detailing 2,385,960 common shares outstanding after an offering. |
| 08/14/2025 | Date of event which requires the filing of this statement. |
Keywords
ReShape Lifesciences, L1 Capital, Schedule 13G, Beneficial Ownership, Common Stock, Medical Devices, Weight Management
Disclaimer:The information provided here is for general informational purposes only and does not constitute financial advice, recommendation, or endorsement of any kind. It may contain errors or omissions. You should not rely on this information to make financial decisions. Always seek the advice of a qualified financial professional before making any investment or financial decisions. Use of this information is at your own risk.